Marker Therapeutics, Inc. (MRKR)
1.41
+0.09
(+6.82%)
USD |
NASDAQ |
Apr 06, 16:00
1.41
0.00 (0.00%)
After-Hours: 19:13
Marker Therapeutics SG&A Expense (TTM) : 4.185M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Viridian Therapeutics, Inc. | 95.31M |
| Tenaya Therapeutics, Inc. | 24.72M |
| ACADIA Pharmaceuticals, Inc. | 548.89M |
| electroCore, Inc. | 38.21M |
| Agenus, Inc. | 54.39M |